Michel baijot

Board Director and Chairman biotechs and big pharmas

Michel Baijot, Ph.D., has served as board director since 2022. Dr Michel Baijot is board director of Sinovac. Chairman of the White Fund and OncoRadiomics.
He has spent more than 25 years in various executive positions with bioMerieux as Corporate Director Molecular Diagnostics, with Innogenetics as VP of Business Development, with GSK Vaccines as VP of strategy, licensing and M&A, with Janssen Crucell Vaccines as Chief Business Officer, with Serum Institute of India as Executive Director Europe.
He has been Chairman of the Belgian Biotech Association for 5 years.
Dr Michel Baijot is a chemical engineer and holds a Ph.D. in molecular biology from University of Louvain (Belgium).